Ryman Healthcare Limited
RYHTY
$7.45
-$0.04-0.53%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 411.59M | 402.58M | 396.78M | 385.88M | 372.73M |
| Total Other Revenue | 33.06M | 30.97M | 29.07M | 24.79M | 20.43M |
| Total Revenue | 444.64M | 433.55M | 425.85M | 410.68M | 393.16M |
| Cost of Revenue | 426.28M | 409.65M | 396.04M | 373.29M | 348.56M |
| Gross Profit | 18.36M | 23.91M | 29.81M | 37.38M | 44.60M |
| SG&A Expenses | -- | -- | -- | -- | -- |
| Depreciation & Amortization | 26.16M | 24.97M | 23.99M | 23.23M | 22.36M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 452.45M | 434.61M | 420.04M | 396.53M | 370.92M |
| Operating Income | -7.80M | -1.06M | 5.81M | 14.15M | 22.24M |
| Income Before Tax | -69.08M | -85.12M | -99.78M | -14.97M | 68.77M |
| Income Tax Expenses | -15.83M | -59.61M | -103.56M | -94.56M | -85.06M |
| Earnings from Continuing Operations | -53.26 | -25.51 | 3.78 | 79.59 | 153.83 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -53.26M | -25.51M | 3.78M | 79.59M | 153.83M |
| EBIT | -7.80M | -1.06M | 5.81M | 14.15M | 22.24M |
| EBITDA | 15.46M | 21.09M | 27.06M | 32.11M | 35.71M |
| EPS Basic | -0.08 | -0.04 | 0.01 | 0.12 | 0.24 |
| Normalized Basic EPS | -0.07 | -0.06 | -0.04 | -0.09 | -0.13 |
| EPS Diluted | -0.08 | -0.04 | 0.01 | 0.12 | 0.24 |
| Normalized Diluted EPS | -0.07 | -0.06 | -0.04 | -0.09 | -0.13 |
| Average Basic Shares Outstanding | 2.75B | 2.75B | 2.75B | 2.60B | 2.44B |
| Average Diluted Shares Outstanding | 2.75B | 2.75B | 2.75B | 2.60B | 2.44B |
| Dividend Per Share | -- | -- | -- | 0.00 | 0.00 |
| Payout Ratio | -- | -- | -- | 0.04% | 0.04% |
